Details for New Drug Application (NDA): 019807
✉ Email this page to a colleague
The generic ingredient in KERLEDEX is betaxolol hydrochloride; chlorthalidone. There are eleven drug master file entries for this compound. Additional details are available on the betaxolol hydrochloride; chlorthalidone profile page.
Summary for 019807
Tradename: | KERLEDEX |
Applicant: | Sanofi Aventis Us |
Ingredient: | betaxolol hydrochloride; chlorthalidone |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 5MG;12.5MG | ||||
Approval Date: | Oct 30, 1992 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 10MG;12.5MG | ||||
Approval Date: | Oct 30, 1992 | TE: | RLD: | No |
Expired US Patents for NDA 019807
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Sanofi Aventis Us | KERLEDEX | betaxolol hydrochloride; chlorthalidone | TABLET;ORAL | 019807-001 | Oct 30, 1992 | ⤷ Sign Up | ⤷ Sign Up |
Sanofi Aventis Us | KERLEDEX | betaxolol hydrochloride; chlorthalidone | TABLET;ORAL | 019807-002 | Oct 30, 1992 | ⤷ Sign Up | ⤷ Sign Up |
Sanofi Aventis Us | KERLEDEX | betaxolol hydrochloride; chlorthalidone | TABLET;ORAL | 019807-002 | Oct 30, 1992 | ⤷ Sign Up | ⤷ Sign Up |
Sanofi Aventis Us | KERLEDEX | betaxolol hydrochloride; chlorthalidone | TABLET;ORAL | 019807-001 | Oct 30, 1992 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription